NewAmsterdam Pharma Company NV (NAMS) EUR0.12
Sell:$34.60Buy:$34.65
$0.46
(1.30%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$34.60
Buy:$34.65
Change:$0.46
(1.30%)
$0.46
(1.30%)Prices delayed by at least 15 minutes
Sell:$34.60
Buy:$34.65
Change:$0.46
(1.30%)
$0.46
(1.30%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 26 December 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 43,872 | $35.30 | $1,548,681.60 | 15,000 |
| 24 December 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 26,011 | $35.68 | $928,072.48 | 15,000 |
| 23 December 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 75,117 | $36.21 | $2,719,986.57 | 15,000 |
| 15 September 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 660 | $23.70 | $15,638.90 | 3,028,524 |
| 9 September 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 53,104 | $25.31 | $1,344,062.24 | 111,896 |
| 9 September 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 96,896 | $26.11 | $2,529,954.56 | 15,000 |
| 8 September 2025 | FRAZIER LIFESCIENCES SPONSOR LLCVenture Capital | Buy Regular purchase transaction | 1,260 | $24.99 | $31,487.40 | 3,027,864 |
| 3 September 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 18,073 | $25.09 | $453,451.57 | 15,000 |
| 25 August 2025 | Louise Frederika KooijChief Accounting Officer | Sell Regular sell transaction (market) | 8,269 | $24.86 | $205,567.34 | 15,000 |
| 22 August 2025 | Johannes Jacob Pieter KasteleinPresident | Sell Regular sell transaction (market) | 42,342 | $25.08 | $1,061,937.36 | 76,960 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 March 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 150,000 | $20.37 | $3,055,500.00 | 15,000 |
| 23 December 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 75,117 | $36.21 | $2,719,986.57 | 15,000 |
| 9 September 2025 | Louise Frederika KooijChief Accounting Officer | Sell Option/Award related | 96,896 | $26.11 | $2,529,954.56 | 15,000 |
| 17 March 2025 | Douglas F KlingCOO | Sell Option/Award related | 100,000 | $23.34 | $2,334,000.00 | 44,000 |
| 15 May 2025 | Douglas F KlingCOO | Sell Option/Award related | 100,000 | $18.38 | $1,863,500.00 | 44,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.